Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-030736
Filing Date
2010-05-27
Accepted
2010-05-27 17:09:56
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v186780_10k.htm 10-K 2877848
2 v186780_ex4-3.htm EX-4.3 71516
3 v186780_ex10-22.htm EX-10.22 272945
4 v186780_ex31-1.htm EX-31.1 16946
5 v186780_ex31-2.htm EX-31.2 17067
6 v186780_ex32-1.htm EX-32.1 7713
7 v186780_ex32-2.htm EX-32.2 7638
  Complete submission text file 0001144204-10-030736.txt   3273230
Mailing Address 5001 SPRING VALLEY ROAD SUITE 1040 - WEST DALLAS TX 75244
Business Address 5001 SPRING VALLEY ROAD SUITE 1040 - WEST DALLAS TX 75244 972-455-8950
HEMOBIOTECH, INC. (Filer) CIK: 0001301348 (see all company filings)

EIN.: 330995817 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51334 | Film No.: 10863455
SIC: 2836 Biological Products, (No Diagnostic Substances)